期刊文献+

维生素D受体基因多态性与肺腺癌易感性的关系 被引量:2

Relationship between gene polymorphisms of vitamin D receptor and susceptibility of lung adenocarcinoma
下载PDF
导出
摘要 目的探讨维生素D受体(VDR)等位基因多态性与肺腺癌易感性的关系。方法 172例河北汉族肺腺癌患者和180例健康对照。采用聚合酶链反应-限制性片段长度多态性的方法对VDR的Bsm1、Fok1等位基因多态性与肺腺癌的关系进行研究。结果肺腺癌组VDR基因Bsm1位点基因型分布、等位基因分布Fok1位点基因型分布与健康对照组比较差异有统计学意义(χ2值分别为8.111和6.492,P<0.05)。Fok1位点基因型分布,其等位基因分布与健康对照组比较差异无统计学意义(P>0.05)。结论 VDR基因Bsm1位点多态性与肺腺癌发病风险相关联。Bsm1位点B等位基因可能增加肺腺癌的发病风险。VDR基因Fok1位点多态性与肺腺癌发病风险可能关联。 Objective To explore the correlation between gene polymorphisms of vitamin D receptor ( VDR) and susceptibility of lung adenocarcinoma .Methods The 172 patients with lung adenocarcinoma ( lung adenocarcinoma group ) and 180 healthy subjects (control group) were enrolled in the study,and all the subjects were Chinese Han people in Hebei province.The correlation between allele polymorphism of Bsm 1,Fok1 site of VDR and lung adenocarcinoma was analyzed by polymerase chain reaction-restriction fragment length polymorphism method .Results There were significant differences in genotype distribution and Bsm 1 genotype distribution of VDR gene between lung adenocarcinoma group and control group (χ2=8.111 and 6.492, P 〈0.05).However there were no significant differences in genotype distribution and Bsm 1 genotype distribution of VDR gene between lung adenocarcinoma group and control group ( P 〉0.05).Conclusion Bsm1 gene site polymorphism of VDR gene is closely correlated to pathogenesis risk of advanced lung adenocarcinoma .Bsm1 B allele may increase the pathogenesis risk of lung cancer .Fok1 site polymorphism of VDR may be related with pathogenesis risk of lung cancer.
出处 《河北医药》 CAS 2014年第12期1780-1782,共3页 Hebei Medical Journal
关键词 多态性 维生素D 肺肿瘤 易感性 polymorphisms vitamin D lung neoplasms susceptibility
  • 相关文献

参考文献10

二级参考文献115

  • 1姜淑娟,王英田,白雪丽,李怀臣,陈方方.1,25二羟基维生素D_3对肺腺癌细胞株生长及凋亡的影响[J].肿瘤防治杂志,2005,12(20):1542-1545. 被引量:11
  • 2Michael Pirozynski. 100 years of lung cancer[J].Respir Med, 2006, 100:2073- 2084. 被引量:1
  • 3Travis WD, Brambilla E, Muller Hermelink HK, et al. Pathology and Genetics: Turnouts of the Lung, Pleura, Thymus and Heart[R]. Leon: IARC Press, 2004. 被引量:1
  • 4Peterson P, Hanan N, Fossella F, et al. The differential efficacy of pemetrexed according to NSCLC histology; a review of two Phase III studies[J]. Oncol, 2009, 14(3):253-263. 被引量:1
  • 5Ciuleanu. Pemetrexed/BSC vs Placebo/BSC in NSCLC[R]. Annual Meeting of Clinical Oncology, 2008. 被引量:1
  • 6Scaqliotto GV, Parikh P, Von Pawel J, et al. Phase III Study Comparing Cisplatin Plus Gemcitabine with Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced Stage Non-Small Cell Lung Cancer[J]. J Clin Oncol, 2008, 26 (27) : 3543-3557. 被引量:1
  • 7Burdett S, Stephens R, Stewart L, et al. Chemotherapy in ad- dition to supportive care improves survival in advanced non- small cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials [J]. J Clin Oncol, 2008, 26(28): 4617-4625. 被引量:1
  • 8Ardizzoni A, Boni L, Tiseo M, et al. Cisplatin-versus carbo- platin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-a nalysis[J].J Natl Cancer Inst, 2007, 99(11) : 847-857. 被引量:1
  • 9Georgoulias V, Papadakis E, Alexopoulos A, et al. Platinum- based and nomplatinum based chemotherapy in advanced non- small-cell lung cancer: a randomised muhieentre trial[J]. Lancet, 2001, 35(9267): 1478- 1484. 被引量:1
  • 10Sigmond J, Backus HH, Wouters D, et al. Induction of resistance to the multitargeted antifolate pemetrexed (ALIM TA) in WiDr human coloncancer cells is associated with thymi dylate synthase overcxpression [J]. Biochem Pharmacol 2003, 66(3): 431-438. 被引量:1

共引文献29

同被引文献27

  • 1JACOBY E, CHIEN CD, FRY TL Murine models of acute leukemia important tools in current pediatric leukemia research Front Oncol, 2014, 4(95): 1-13. 被引量:1
  • 2SISON EA, BROWN P. Does hematopoietic stem cell transplan- tation benefit i~afants with acute leukemia[J]. Hematology Am Soc Hematol Educ Program, 2013, 2013: 601-604. 被引量:1
  • 3LIANG KL, RISHI L, KEESHAN IL Tribbles in acute leukemia[J]. Blood, 2013, 121(21): 4265-4270. 被引量:1
  • 4WINTER SS. Pediatric acute leukemia therapies informed by molecular analysis of high-risk disease[J]. Hematology Am Soc Hematol Educ Program, 2011, 2011: 366-373. 被引量:1
  • 5HE Q, ANANABA GA, PATRICKSON J, et al. Chlamydial in- fection in vitamin D receptor knockout mice is more intense and prolonged than in wild-type mice[J]. J Steroid Biochem Mol Biol, 2013, 135: 7-14. 被引量:1
  • 6ZHAO Y, LIAO S, HE J, et al. Association of vitamin D recep- tor gene polymorphisms with metabolic syndrome: a case-control design of population-based cross-sectional study in north China[J]. Lipids Health Dis, 2014, 13: 129. 被引量:1
  • 7AREESHI MY, MANDAL RK, AKHTER N, et al. Evaluating the association between taqi variant of vitamin Dreceptor gene and susceptibility to tuberculosis: a meta-analysis[J]. Toxic& Int, 2014, 21(2): 140-147. 被引量:1
  • 8GHORBANIHAGHJO A, ARGANI H, SAMADI N, et al. Rela- tionship between vitamin D receptor gene foki and apai polymor- phisms and serum levels of fetuin-A, vitamin D, and parathyroid hormone in patients on hemodialysis[J]. Iran J Kidney Dis, 2014, 8(5): 394-400. 被引量:1
  • 9ZHANG K, SONG L. Association between vitamin D receptor gene polymorphisms and breast cancer risk: a meta-analysis of 39 studies[J]. PLoS One, 2014, 9(4): 1-9. 被引量:1
  • 10MANCHANDA PK, BID HK. Vitamin D receptor and type 2 diabetes mellitus: growing therapeutic opportunities[J]. Indian J Hum Genet, 2012, 18(3): 274-275. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部